MOLINA HEALTHCARE, INC.
Business
MOLINA HEALTHCARE, INC. provides managed healthcare services under Medicaid, Medicare and through state insurance marketplaces. It offers health plan products and services including Medicaid managed care, Medicare Advantage and dual‑eligible plans (D‑SNP, HIDE, FIDE), Marketplace ACA‑compliant plans, long‑term services and supports, care management, utilization management and pharmacy management. Its operations are organized into four reportable segments—Medicaid, Medicare, Marketplace and Other—and it arranges care through provider networks, PBMs and centralized administrative services. Molina serves members across multiple U.S. states and distributes products via state contracts, independent agents, brokers, online channels and auto‑assignment mechanisms.
Summary from filing dated 2025-02-11
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Premium revenue | 43,052 | 38,627 | 32,529 | 30,883 | 26,855 | |
| Premium tax revenue | 1,863 | 1,486 | 1,069 | 873 | 787 | |
| Investment income | 420 | 452 | 394 | 143 | 52 | |
| Other revenue | 91 | 85 | 80 | 75 | 77 | |
| Total revenue | 45,426 | 40,650 | 34,072 | 31,974 | 27,771 | |
| Medical care costs | 39,488 | 34,428 | 28,669 | 27,175 | 23,704 | |
| General and administrative expenses | 3,009 | 2,743 | 2,462 | 2,311 | 2,068 | |
| Premium tax expenses | 1,863 | 1,486 | 1,069 | 873 | 787 | |
| Depreciation and amortization | 195 | 186 | 171 | 176 | 131 | |
| Other | 90 | 100 | 128 | 58 | 61 | |
| Total operating expenses | 44,645 | 38,943 | 32,499 | 30,801 | 26,751 | |
| Operating income | 781 | 1,707 | 1,573 | 1,173 | 1,020 | |
| Interest expense | 192 | 118 | 109 | 110 | — | |
| Income before income tax expense | 589 | 1,589 | 1,464 | 1,063 | 875 | |
| Income tax expense | 117 | 410 | 373 | 271 | 216 | |
| Net income | 472 | 1,179 | 1,091 | 792 | 659 | |
| Basic (in dollars per share) | 8.93 | 20.52 | 18.91 | 13.72 | 11.4 | |
| Diluted (in dollars per share) | 8.92 | 20.42 | 18.77 | 13.55 | 11.25 | |
| Basic (in shares) | 53 | 57 | 58 | 58 | 58 | |
| Diluted (in shares) | 53 | 58 | 58 | 59 | 59 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 4,248 | 4,662 | 4,848 | 4,006 | 4,438 | |
| Investments | 4,008 | 4,325 | 4,259 | 3,499 | 3,202 | |
| Receivables | 3,533 | 3,299 | 3,104 | 2,302 | 2,177 | |
| Prepaid expenses and other current assets | 655 | 487 | 331 | 277 | 247 | |
| Total current assets | 12,444 | 12,773 | 12,542 | 10,084 | 10,064 | |
| Property, equipment, and capitalized software, net | 301 | 288 | 270 | 259 | 396 | |
| Goodwill and intangible assets, net | 2,195 | 1,938 | 1,449 | 1,390 | 1,252 | |
| Restricted investments | 299 | 286 | 261 | 238 | 212 | |
| Deferred income taxes, net | 178 | 207 | 227 | 220 | 106 | |
| Other assets | 147 | 138 | 143 | 123 | 179 | |
| Total assets | 15,564 | 15,630 | 14,892 | 12,314 | 12,209 | |
| Medical claims and benefits payable | 4,887 | 4,640 | 4,204 | 3,528 | 3,363 | |
| Amounts due government agencies | 1,326 | 1,874 | 2,294 | 2,079 | 2,472 | |
| Accounts payable, accrued liabilities and other | 1,093 | 1,331 | 1,252 | 889 | 842 | |
| Deferred revenue | 66 | 51 | 418 | 359 | 370 | |
| Total current liabilities | 7,372 | 7,896 | 8,168 | 6,855 | 7,047 | |
| Long-term debt | 3,766 | 2,923 | 2,180 | 2,176 | 2,173 | |
| Finance lease liabilities | 184 | 195 | 205 | 215 | 219 | |
| Other long-term liabilities | 173 | 120 | 124 | 104 | 140 | |
| Total liabilities | 11,495 | 11,134 | 10,677 | 9,350 | 9,579 | |
| Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024 | 0 | 0 | 0 | 0 | 0 | |
| Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 452 | 462 | 410 | 328 | 236 | |
| Accumulated other comprehensive income (loss) | 15 | −57 | −82 | −160 | −5 | |
| Retained earnings | 3,602 | 4,091 | 3,887 | 2,796 | 2,399 | |
| Total stockholders equity | 4,069 | 4,496 | 4,215 | 2,964 | 2,630 | |
| Total liabilities and stockholders equity | 15,564 | 15,630 | 14,892 | 12,314 | 12,209 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 195 | 186 | 171 | 176 | 131 | |
| Deferred income taxes | 43 | 53 | −31 | −66 | −24 | |
| Share-based compensation | 47 | 116 | 115 | 103 | 72 | |
| Other, net | −3 | 8 | 2 | 8 | 33 | |
| Receivables | −145 | −78 | −778 | −95 | −415 | |
| Prepaid expenses and other current assets | 52 | −57 | −69 | −124 | −19 | |
| Medical claims and benefits payable | −132 | −40 | 580 | 153 | 471 | |
| Amounts due government agencies | −591 | −453 | 196 | −428 | 1,046 | |
| Accounts payable, accrued liabilities and other | −221 | 115 | 328 | 55 | 138 | |
| Deferred revenue | −51 | −367 | 59 | −11 | −5 | |
| Income taxes | −201 | −18 | −2 | 2 | 7 | |
| Net cash (used in) provided by operating activities | −535 | 644 | 1,662 | 773 | 2,119 | |
| Purchases of investments | −751 | −1,132 | −1,433 | −1,913 | −2,713 | |
| Proceeds from sales and maturities of investments | 1,408 | 1,111 | 772 | 1,398 | 1,329 | |
| Net cash paid in business combinations | −245 | −344 | −3 | −134 | −129 | |
| Purchases of property, equipment and capitalized software | −101 | −100 | −84 | −91 | −77 | |
| Other, net | 1 | 1 | 4 | −50 | −63 | |
| Net cash provided by (used in) investing activities | 312 | −464 | −744 | −790 | −1,653 | |
| Proceeds from borrowings under credit facility and term loans | 1,100 | 300 | 0 | — | — | |
| Repayment of credit facility and term loans | −1,100 | −300 | 0 | 0 | 0 | |
| Common stock purchases | −1,000 | −1,000 | 0 | −400 | −128 | |
| Proceeds from senior notes offerings, net of issuance costs | 838 | 740 | 0 | 0 | 740 | |
| Common stock withheld to settle employee tax obligations | −37 | −57 | −60 | −54 | −53 | |
| Other, net | 29 | −30 | 2 | 33 | 1 | |
| Net cash used in financing activities | −170 | −347 | −58 | −441 | −183 | |
| Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents | −393 | −167 | 860 | −458 | 283 | |
| Cash paid during the period for interest | 181 | 121 | 108 | 108 | 127 |